InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

Current share price for ATX : $0.140 0.01 (6.67%)+

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$72 Letter to Shareholders End of Year Summary and 2023 Plans 20 Dec 2022 9:08AM $0.088 $0.140 risen by 59.09%
$72 Final Director's Interest Notice - Dr. John Lambert 1 Dec 2022 10:10AM $0.095 $0.140 risen by 47.37%
$72 ACCENT Trial Recruitment Progress 29 Nov 2022 2:15PM $0.097 $0.140 risen by 44.33%
$72 Appendix 4D and Financial Report Half Year ended 30 Sep 22 18 Nov 2022 8:19AM $0.105 $0.140 risen by 33.33%
$72 Amplia Appoints Dr Christopher Burns CEO & Managing Director 7 Nov 2022 8:47AM $0.099 $0.140 risen by 41.41%
$72 Quarterly Activities and Cashflow Reports - Sep 2022 Qtr 28 Oct 2022 8:51AM $0.099 $0.140 risen by 41.41%
$72 Notification regarding unquoted securities - ATX 10 Oct 2022 8:34AM $0.100 $0.140 risen by 40%
$72 AMP886 Activity in Acute Myeloid Leukemia 3 Oct 2022 8:20AM $0.105 $0.140 risen by 33.33%
$72 AACR Conference Presentation 14 Sep 2022 8:06AM $0.100 $0.140 risen by 40%
$72 CEO Resignation 12 Sep 2022 9:33AM $0.115 $0.140 risen by 21.74%
$72 Notification regarding unquoted securities - ATX 7 Sep 2022 8:38AM $0.100 $0.140 risen by 40%
$72 Change of Director's Interest Notice - Dr. Warwick Tong 7 Sep 2022 8:12AM $0.100 $0.140 risen by 40%
$72 Change of Director's Interest Notice - Dr. Robert Peach 7 Sep 2022 8:12AM $0.100 $0.140 risen by 40%
$72 Change of Director's Interest Notice - Dr. Christopher Burns 7 Sep 2022 8:12AM $0.100 $0.140 risen by 40%
$72 Change of Director's Interest Notice - Mrs. Jane Bell 7 Sep 2022 8:12AM $0.100 $0.140 risen by 40%
$72 Change of Director's Interest Notice - Dr. John Lambert 6 Sep 2022 8:14AM $0.100 $0.140 risen by 40%
$72 Notification of cessation of securities - ATX 2 Sep 2022 5:06PM $0.100 $0.140 risen by 40%
$72 Amplia Receives $1.8m R&D Tax Incentive 31 Aug 2022 8:45AM $0.115 $0.140 risen by 21.74%
$72 Results of Annual General Meeting 25 Aug 2022 12:06PM $0.115 $0.140 risen by 21.74%
$72 CEO & Managing Director Presentation to AGM 25 Aug 2022 10:38AM $0.115 $0.140 risen by 21.74%
$72 Annual General Meeting - ESOP and New Constitution 17 Aug 2022 8:15AM $0.098 $0.140 risen by 42.86%
$72 Employee Security Ownership Plan 17 Aug 2022 8:14AM $0.098 $0.140 risen by 42.86%
$72 Change of Director's Interest Notice - Dr. Warwick Tong 4 Aug 2022 12:17PM $0.110 $0.140 risen by 27.27%
$72 First Patient Recruited to ACCENT Trial in Pancreatic Cancer 2 Aug 2022 11:53AM $0.095 $0.140 risen by 47.37%
$72 Quarterly Activities and Cashflow Reports - June 2022 Qtr 28 Jul 2022 10:44AM $0.094 $0.140 risen by 48.94%

251 - 275 of 538 results

Page 11 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.